On the day, 1546761 shares were traded.
Ratios:
Our analysis of SBH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.28. For the most recent quarter (mrq), Quick Ratio is recorded 0.45 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 3.06 whereas as Long-Term Debt/Eq ratio is at 2.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on December 15, 2022, initiated with a Overweight rating and assigned the stock a target price of $15.
On August 12, 2022, Cowen Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $17.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 22 ’24 when Sherman Scott C sold 10,000 shares for $12.95 per share. The transaction valued at 129,520 led to the insider holds 35,014 shares of the business.
Paulonis Denise bought 4,000 shares of SBH for $45,160 on Dec 12 ’23. The President & CEO now owns 170,826 shares after completing the transaction at $11.29 per share.
Valuation Measures:
As of this moment, Sally’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.55, and their Forward P/E ratio for the next fiscal year is 5.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 2.00.
Stock Price History:
Over the past 52 weeks, SBH has reached a high of $14.64, while it has fallen to a 52-week low of $7.21.
Shares Statistics:
A total of 106.27M shares are outstanding, with a floating share count of 103.35M. Insiders hold about 1.46% of the company’s shares, while institutions hold 115.67% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by VanEck Semiconductor ETF analysts. The consensus estimate for the next quarter is $19.47, with high estimates of $122.07 and low estimates of $18.55.
Analysts are recommending an EPS of between $Healthcare and $Utilities for the fiscal current year, implying an average EPS of $Technology.
